FRM
EDIT icon

Fox Run Management’s Editas Medicine EDIT Stock Holding History

Fox Run Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-14,119
Closed -$173K – 690
2022
Q3 		$173K Buy
+14,119
New +$220K 0.07% 503
2021
Q4 		– Sell
-10,534
Closed -$433K – 529
2021
Q3 		$433K Buy
+10,534
New +$577K 0.27% 112
2021
Q1 		– Sell
-2,968
Closed -$208K – 240
2020
Q4 		$208K Buy
+2,968
New +$122K 0.42% 135
2017
Q3 		– Sell
-31,100
Closed -$522K – 720
2017
Q2 		$522K Buy
31,100
+18,900
+155% +$341K 0.18% 204
2017
Q1 		$272K Buy
+12,200
New +$253K 0.11% 397

Other funds holding EDIT

State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Fox Run Management's EDIT Position: Q4 2022 in Review

Fox Run Management sold out of Editas Medicine (EDIT) in Q4 2022, closing a stake of 14,119 shares — an estimated $173K sold.

Fox Run Management first reported a position in EDIT in Q1 2017 and held it in 5 quarters. The position peaked at $522K in Q2 2017. 250 funds tracked by Wall St. Rank hold EDIT as of Q4 2022.

  • Fox Run Management reported no remaining Editas Medicine position as of Q4 2022 after selling out during the quarter.
  • Fox Run Management sold 14,119 Editas Medicine shares in Q4 2022, an estimated $173K.
  • Fox Run Management first reported a position in Editas Medicine in Q1 2017 and held it in 5 quarters.
  • Fox Run Management's Editas Medicine position peaked at $522K in Q2 2017.
  • 250 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2022.

Based on Fox Run Management's 13F filing for Q4 2022, filed 7 Feb 2023.